Understand the gut
Study which microorganisms and biological processes are present in a sample. The planned approach uses DNA sequencing to explore the microbiome.
OUR APPROACH
From complex biology
to clearer questions.
We are developing a way to connect gut microbiome research with the people it could one day help. Every step needs careful evaluation.
In development · Pilot study in preparationTHE PLANNED JOURNEY
A closer look.
Step by step.
Bring the context together
Investigate microbiome findings alongside relevant clinical information, using research methods and machine learning models developed in house.
Make the findings understandable
Develop clear, evidence-linked reports for discussion with clinicians — showing what is known, what is uncertain and what needs further research.
This is the research pathway we are building. The prototype runs on example data today; a test kit, laboratory service or patient report would follow only after the pilot study and the necessary approvals.
HOW IT FITS TOGETHER
From a sample
to a conversation.
Six steps connect a sample to an appointment. Neurabi builds the four in the middle; the laboratory and the appointment belong to the people around it.
- 01
Sample
A stool sample goes to a laboratory, which sequences it.
- 02
Measurements
54 measurements arrive: bacterial types and gene-based processes, each as a share of the sample.
- 03
Comparison
Each one is placed against a reference interval modelled for age, sex and body mass index.
- 04
Evidence
Saved research is attached to each result, with its study design and its limits.
- 05
Review
A clinician weighs every result and decides what to discuss. An assistant explains the sources; the clinician decides.
- 06
Conversation
The released report is read together at the appointment, in plain language.
Machine learning helps make the measurements as accurate and clear as we can. One frozen model version is used, so a later sample can be compared with the same reference.
Careful by design.
Evidence before promises
Clinical usefulness and safety must be evaluated through appropriate studies.
People before predictions
Any future tool is intended to support a conversation with a clinician.
Clarity about uncertainty
Research findings, limitations and unanswered questions belong together.
OUR FIRST RESEARCH FOCUS
Starting with
neurological conditions.
Our initial research priorities are Alzheimer’s disease, Parkinson’s disease and multiple sclerosis. The exact pilot population and protocol are being developed.
01
Alzheimer’s disease
02
Parkinson’s disease
03
Multiple sclerosis
THE NEXT CHAPTER STARTS WITH A QUESTION.
Let’s understand
more, together.
A clinician, a researcher, a patient organisation, or simply curious? We’d like to hear from you.
Get in touch